logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Bacterial Conjunctivitis

    FiltersReset Filters
    8 results

    • besivance

      (Besifloxacin)
      Bausch & Lomb Incorporated
      Usage: BESIVANCE (besifloxacin ophthalmic suspension) 0.6% is indicated for the treatment of bacterial conjunctivitis caused by susceptible bacteria, including Haemophilus influenzae and various Staphylococcus, Streptococcus, and Moraxella species. Efficacy for some organisms was studied in fewer than 10 infections.

    • ciloxan

      (ciprofloxacin hydrochloride)
      Sandoz Inc
      Usage: CILOXAN® (ciprofloxacin ophthalmic ointment) 0.3% is indicated for treating bacterial conjunctivitis caused by susceptible strains of Gram-positive bacteria (e.g., Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae) and Gram-negative bacteria (e.g., Haemophilus influenzae).

    • levofloxacin

      (LEVOFLOXACIN)
      Advagen Pharma Limited
      Usage: Levofloxacin ophthalmic solution is indicated for treating bacterial conjunctivitis caused by susceptible strains of Gram-positive bacteria (e.g., Staphylococcus, Streptococcus) and Gram-negative bacteria (e.g., Haemophilus, Acinetobacter). Efficacy for some organisms was evaluated in fewer than 10 infections.

    • moxifloxacin ophthalmic solution

      (Moxifloxacin Ophthalmic)
      Gland Pharma Limited
      Usage: Moxifloxacin ophthalmic solution is indicated for treating bacterial conjunctivitis caused by susceptible strains, including various species of Staphylococcus, Streptococcus, Corynebacterium, Acinetobacter, Haemophilus, and Chlamydia trachomatis. Some organisms have limited data supporting efficacy.

    • moxifloxacin ophthalmic solution

      (Moxifloxacin ophthalmic solution)
      Alembic Pharmaceuticals Inc.
      Usage: Moxifloxacin ophthalmic solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of various bacteria, including Staphylococcus, Streptococcus, Acinetobacter, Corynebacterium, and Haemophilus species, as well as Chlamydia trachomatis.

    • moxifloxacin ophthalmic solution

      (Moxifloxacin)
      Lifestar Pharma LLC
      Usage: Moxifloxacin ophthalmic solution is indicated for treating bacterial conjunctivitis caused by susceptible strains, including Corynebacterium species, various Staphylococcus species, Streptococcus pneumoniae, Haemophilus species, and Chlamydia trachomatis, among others. Some organisms were studied in fewer than 10 infections.

    • polymyxin b sulfate and trimethoprim sulfate

      (polymyxin b sulfate and trimethoprim sulfate)
      Somerset Therapeutics, LLC
      Usage: Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution is indicated for treating surface ocular bacterial infections, including acute bacterial conjunctivitis and blepharoconjunctivitis, caused by susceptible strains of bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa.

    • vigamox

      (moxifloxacin hydrochloride)
      Harrow Eye, LLC
      Usage: VIGAMOX® is indicated for treating bacterial conjunctivitis caused by susceptible strains, including Corynebacterium species, Micrococcus luteus, Staphylococcus species, Streptococcus pneumoniae, Haemophilus influenza, and Chlamydia trachomatis. Some organisms had limited efficacy data.